CFO of Harpoon Therapeutics Inc (30-Year Financial, Insider Trades) Georgia Erbez (insider trades) bought 6,700 shares of HARP on 01/21/2020 at an average price of $14.09 a share. The total cost of this purchase was $94,403.
Harpoon Therapeutics Inc has a market cap of $340.257 million; its shares were traded at around $13.81 with and P/S ratio of 63.35. GuruFocus has detected 1 severe warning sign with Harpoon Therapeutics Inc. .
CFO Recent Trades:
- CFO Georgia Erbez bought 6,700 shares of HARP stock on 01/21/2020 at the average price of $14.09. The price of the stock has decreased by 1.99% since.
Directors and Officers Recent Trades:
- Chief Medical Officer Natalie Sacks sold 1,521 shares of HARP stock on 01/16/2020 at the average price of $14.94. The price of the stock has decreased by 7.56% since.
- Chief Scientific Officer Holger Wesche sold 10,000 shares of HARP stock on 01/02/2020 at the average price of $14.4. The price of the stock has decreased by 4.1% since.
- Chief Medical Officer Natalie Sacks sold 5,826 shares of HARP stock on 01/02/2020 at the average price of $14.18. The price of the stock has decreased by 2.61% since.
- Director Patrick Baeuerle sold 87,379 shares of HARP stock on 12/27/2019 at the average price of $15.98. The price of the stock has decreased by 13.58% since.
For the complete insider trading history of HARP, click here
.
